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The utilization of transgenic plants expressing recombinant antigens to be used in the formulation of experimental
immunogens has been recently communicated. We report here the development of transgenic plants of alfalfa expressing the
structural protein VP1 of foot and mouth disease virus (FMDV). The presence of the transgenes in the plants was confirmed
by PCR and their specific transcription was demonstrated by RT-PCR. Mice parenterally immunized using leaf extracts or
receiving in their diet freshly harvested leaves from the transgenic plants developed a virus-specific immune response.
Animals immunized by either method elicited a specific antibody response to a synthetic peptide representing amino acid
residues 135–160 of VP1, to the structural protein VP1, and to intact FMDV particles. Additionally, the immunized mice were
protected against experimental challenge with the virus. We believe this is the first report demonstrating the induction of a
protective systemic antibody response in animals fed transgenic plants expressing a viral antigen. These results support the
feasibility of producing edible vaccines in transgenic forage plants, such as alfalfa, commonly used in the diet of domestic
animals even for those antigens for which a systemic immune response is required. © 1999 Academic PressKey Words: FMDV; infectious immunity virus; vaccination.
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The utilization of plants for the production of foreign
roteins to be used as experimental immunogens was
irst reported by Mason et al. in 1992. Since then, several
roups have used transgenic plants for expressing a
ariety of viral and bacterial antigens (Arakawa et al.,
998; Carrillo et al., 1998; Go´mez et al., 1998; Haq et al.,
995; Mason et al., 1996; McGarvey et al., 1995). Plants
roducing recombinant foreign proteins could be an in-
xpensive source of antigens that could be easily puri-
ied for parenteral inoculation. However, only a reduced
umber of viral or bacterial antigens produced in plants
ave been tested for their immunogenicity when orally
dministered. Some examples are the Norwalk virus
apsid (Mason et al., 1996), the Escherichia coli heat
abile enterotoxin (Haq et al., 1995), and the cholera toxin
subunit (Arakawa et al., 1998). In addition to the pos-
ibility of using plants as bioreactors for the production
f vaccine antigens, as an alternative to conventional
1 This work was supported by Grant BID 802/OC-AR PID 168 from
ECYT-CONICET, Rep. Argentina and by Grant BIO96-1172 from Comi-
io´n Interministerial de Ciencia y Tecnologı´a of Espan˜a.
2 To whom correspondence and reprint requests should be ad-
tressed. Fax: 54-1-621-1743. E-mail: borca@castelar.gov.ar.
347ermentation-based procedures, their utilization as a sys-
em for delivering antigens by the oral route, by including
hem in the diet, has pointed out the necessity of study-
ng the oral immunogenicity of a wide variety of antigens
xpressed by this methodology.
Foot and mouth disease virus (FMDV) is the causative
gent of an economically important disease affecting
eat-producing animals (Brown, 1992). Comprehensive
accination of all susceptible hosts, using inactivated
irus as immunogen, constitutes the basis of all sanitary
lans for the control and eradication of the disease
Brown, 1992). The structural protein VP1 carries critical
pitopes responsible for the induction of neutralizing
ntibodies. The expression of immunogenic areas of VP1
n a diverse range of prokaryotic and eukaryotic systems
as been performed, resulting in effective experimental
mmunogens (DiMarchi et al., 1986; Kleid et al., 1981;
organ and Moore, 1989; Zamorano et al., 1995).
In the present study we utilized VP1 of FMDV serotype
1 Campos (O1C) as a model to investigate the possi-
ility of using transgenic alfalfa plants as a source of
ntigen in the production of a recombinant immunogen
s well as an experimental edible vaccine. The results
resented in this report demonstrate that mice, paren-
erally or orally immunized with leaves obtained from
ransgenic plants, developed a similar virus-specific im-
0042-6822/99 $30.00
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348 WIGDOROVITZ ET AL.une response that was able to protect the animals from
xperimental challenge with the virulent virus.
RESULTS
roduction and genetic analysis of transformed plants
Recombinant pRok.VP1a plasmids (pRok2 binary vec-
or using the cauliflower mosaic virus, CaMV, 35S pro-
oter to drive nominally constitutive transcription of the
loned genes) also contain the selectable marker nptII,
hich permits selection of transformed plants on me-
ium containing kanamycin. Both genes, VP1 and nptII,
re located in the TDNA region of the plasmid, allowing
he stable integration of the recombinant DNA into the
uclear chromosomal DNA of the plant. Plant transfor-
ation with pRok.VP1a was mediated by Agrobacterium
umefaciens.
The presence of the VP1 gene in the transgenic plants
as detected by PCR. The analysis showed the pres-
nce of an amplified product of the expected size (655
p) in all plants transformed with pRok.VP1a (Fig. 1). This
roduct was absent in nontransformed plants as well as
n kanamycin-resistant plants harboring an unrelated
ene. As control, the presence of the nptII gene was also
nvestigated in the same DNA plant samples. A specific
mplification product of 344 bp was consistently present
n all kanamycin-resistant plants but absent from the
ontransformed individuals (Fig. 1).
etection of transcriptional activity in the transgenic
lants
The analysis of transcription of specific genes in the
ransformants was performed by RT-PCR. Plants trans-
ormed with pRok.VP1a presented active transcriptional
ctivity corresponding to the recombinant genes of VP1
FIG. 1. Detection of the VP1 and nptII genes in transgenic plants
sing PCR. Plant DNA was isolated from cell extracts and PCR was
erformed with a pair of primers that specifically amplify DNA frag-
ents of 344 bp from the nptII gene (A) and 655 bp from the VP1 gene
B), respectively. Lane description: nontemplate (A), DNA from pRok
kanamycin-resistant individuals) transformed plants (B and C), DNA
rom pRok.VP1a transformed plant (E–N), pRok.VP1a plasmid (P), MW
arker (D and O).nd nptII along with the housekeeping ITS gene frag- tent, whereas the nontransformed plants showed the
ranscription of only the ITS gene fragment (Fig. 2). To
ule out the possibility of amplification of contaminant
NA in the samples, direct PCR amplification without
everse transcription was performed on the RNA prepa-
ations. No amplified DNA fragments were detectable
nder those conditions, confirming the RNA specificity of
he reaction (Fig. 2).
election of transgenic plants expressing VP1 and
nduction of immune response in intraperitoneally
mmunized mice
The presence of the recombinant protein in all the
eveloped alfalfa clones harboring the VP1 gene was
ested by direct ELISA using the anti-FMDV serum. Ten of
5 lines were positive in at least three sequential deter-
inations (data not shown) and were then selected for
he immunization experiments.
Balb/c mice were immunized ip at days 0, 15, 30, and
5 with approximately 15 to 20 mg of plant tissue emul-
ified in incomplete Freund’s adjuvant (plant extracts
ere prepared by macerating approximately 50 mg of
rozen leaves in 1 ml of PBST). Ten days after the last
noculation, animals were bled and the sera analyzed for
he presence of anti-FMDV antibodies. The experiment
as independently performed twice (Groups A and B in
ig. 3).
Antibodies raised in immunized mice showed a
trong response in ELISA against VP1 as demon-
trated by their reactivity to p135-160 (Figs. 3A and 3B).
he specificity of this anti-VP1 response was con-
irmed by Western blot, using purified FMDV as anti-
FIG. 2. Detection of transcription of the VP1, nptII, and ITS genes in
ransgenic plants using RT-PCR. Plant RNA was isolated from cell
xtracts and RT-PCR was performed with a pair of primers that specif-
cally amplified a DNA fragment of 145 bp of the VP1 gene (A), 344 bp
f the nptII gene (B), and approximately 800 bp containing the ITS
ragment (C), respectively. Lane description: RNA samples shown in
anes B, C, and D were subjected to PCR amplification without the
revious RT reaction as control for DNA contamination. RNA samples
hown in lanes E, F, and G were subjected to PCR amplification after RT
eaction. Nontemplate RT (B and E), RNA from nontransformed plants
C and F), RNA from pRok.VP1a transformed plants (D and G), DNA for
he control of amplification (H), MW marker (A and I).
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349PROTECTIVE ANTIBODY RESPONSE TO FMDV IN MICE IMMUNIZED WITH TRANSGENIC PLANTSen; a pool of sera from mice immunized with plants
xpressing the recombinant protein specifically recog-
ized a protein with the same relative mobility as that
ecognized by an immune serum raised against p135-
60 (Fig. 4). Additionally, the specific immune re-
ponse against FMDV intact particles was analyzed by
LISA. All animals immunized with plants expressing
P1 developed a strong immune response (Figs. 3A
nd 3B). Sera from mice immunized with leaf extract
FIG. 3. Detection of antibodies to p135-160 (p1) (solid bars) and anti
eaf extracts from transformed plants, using ELISA. The figure shows th
orrespond to the mice immunized with each of the 10 different pRok.V
eciprocal of the highest serum dilution that presents OD readings abov
ontransformed plants.rom nontransformed plants showed no reactivity in hither ELISA or Western blot, supporting the specificity
f the immune response induced by the extracts from
lants containing VP1 (Figs. 3A, 3B, and 4).
nduction of an immune response in orally immunized
ice
For the oral immunization experiments adult male
alb/c mice were fed with approximately 0.3 g of freshly
particles (virus) (open bars) in mice intraperitoneally immunized with
lts of two independently performed experiments (A) and (B). Numbers
nsformed plants (a–j). Serum titers are expressed as the log10 of the
e mean OD readings 1 3 SD of sera from five animals immunized with-FMDV
e resu
P1a tra
e of tharvested leaves each time, three times a week for 2
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350 WIGDOROVITZ ET AL.onths. One of the groups received leaves from a pool of
he 10 plants expressing VP1 utilized in parenteral im-
unization, while the control group was fed leaves ob-
ained from nontransformed plants. Ten days after the
ast feeding the presence of anti-FMDV antibodies was
hecked in the blood of the immunized mice. The exper-
ment was performed twice (Groups A and B in Fig. 5),
ndependently. The orally immunized mice showed a
pecific reaction in ELISA against VP1, as determined by
heir reactivity against p135-160 (Figs. 5A and 5B). Again,
his specificity was confirmed by Western blot analysis
sing purified FMDV as antigen; a pool of the orally
mmunized mice recognized a protein of a size similar to
hat recognized by the anti-p135-160 serum. Finally, all
rally immunized mice developed a specific antibody
esponse against whole virus particle (Figs. 5A and 5B).
era from mice fed leaves from nontransformed plants
howed no reactivity in any of the tests performed (Figs.
, 5A, and 5B).
mmunized animals were protected against the virus
hallenge
To test the effectiveness of the induced immune re-
ponse in preventing infection following virus exposure,
he groups of mice orally or intraperitoneally immunized
ith leaves from alfalfa plants expressing VP1 (Figs. 3A,
B, 5A, and 5B) were experimentally challenged with
MDV. Mice were inoculated ip with 104 suckling mouse
ethal doses (SM50LD) of FMDV O1C and 36 h later the
bsence of viremia was considered an indicator of pro-
ection. Interestingly, 77 to 80% of the animals immunized
ntraperitoneally were protected. More importantly, 66 to
5% of the animals fed leaves from VP1 expressing
lants showed protection after the experimental chal-
FIG. 4. Anti-VP1 antibodies detected by Western blot in the sera from
ouse immunized either orally or ip with leaves from recombinant
lants. Lane description: a pool of sera from mice fed (A) or ip immu-
ized (B) with leaves from pRok.VP1a transformed plants, an anti-p135-
60 serum (C), and a pool of sera from mice fed (D) or ip immunized (E)
ith leaves from nontransformed plants, respectively.enge (Tables 1 and 2). eDISCUSSION
Since the concept of using transgenic plants for vac-
ine production was first described by Mason et al.
1992) several authors have described the expression of
accine antigens using this methodology (Arakawa et al.,
998; Carrillo et al., 1998; Go´mez et al., 1998; Haq et al.,
995; Mason et al., 1996; McGarvey et al., 1995). The
emonstration that some of these antigens were immu-
ogenic when orally administered (Arakawa et al., 1998;
aq et al., 1995; Mason et al., 1996) encouraged the
tudy of other antigens expressed in plants in order to
evelop edible vaccines. We have previously demon-
trated that protein VP1 could be expressed as an im-
unogenic antigen in Arabidopsis, an experimental plant
ystem (Carrilo et al., 1998). Now, we have extended our
tudies by expressing this protein in alfalfa, a forage
FIG. 5. Detection of antibodies to p135-160 (p1) (solid bars) and
nti-FMDV particles (virus) (open bars) in mice fed freshly harvested
eaves from transformed plants, using ELISA. The figure shows the
esults from two independently performed experiments (A) and (B).
umbers correspond to the mice fed leaves from a pool of the 10
ifferent pRok.VP1a transformed plants used in Fig. 3. Serum titers are
xpressed as in Fig. 3.
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351PROTECTIVE ANTIBODY RESPONSE TO FMDV IN MICE IMMUNIZED WITH TRANSGENIC PLANTSlant, which can be produced in enough quantity to feed
omestic species susceptible to FMDV. In the present
ork we described the production of transgenic plants
xpressing the structural protein VP1 of FMDV and their
tilization as a source of antigen for the immunization of
xperimental hosts. The plant-derived VP1 was able to
nduce, in parenterally immunized mice and, more impor-
antly, in mice fed leaves from the transgenic plants, a
irus-specific antibody response and protection against
irulent challenge.
All the plant-expressed antigens, which were reported
o be immunogenic when orally administered, were pro-
eins belonging to microorganisms whose native habitat
s the enteric tract (Arakawa et al., 1998; Haq et al., 1995;
ason et al., 1996). Thus, during the immunization pro-
ess, it is expected that these antigens will show a
ertain natural resistance to the physiological digestive
echanisms with the concomitant maintenance of their
mmunogenicity. Interestingly, we found that mice fed
resh leaves expressing VP1 presented a systemic im-
une response to FMDV that was protective against the
xperimental challenge performed by the intraperitoneal
oute. We believe this is the first report showing a sys-
emic protective immune response induced by oral im-
unization with a viral antigen expressed in transgenic
lants. In fact, this result is in agreement with our data
hat demonstrated that mice orally immunized with puri-
ied FMDV particles (as well as with OVA, as a control
ntigen) developed a significant antigen-specific sys-
emic antibody response and protection against experi-
ental challenge (Peralta et al., unpublished results).
Although its quantification was not performed, the
evel of expression of VP1 in the analyzed transgenic
lants was not very significant. The difficulty in detecting
he foreign protein in the plant extract, by Western blot,
nd the necessity of performing several immunizations in
rder to induce a significative immune response indicate
he scarcity of the expressed protein. Thus, the increase
f the amount of foreign protein in the transgenic plants
hould be a goal in the near future. The use of alternative
TABLE 1
Protection against FMDV Challenge in Mice ip Immunized
with Plant Extracts
Mice immunized ip with
Protection ratea
Experiment A Experiment B
Rok.VP1a plant extracts 10/13 (77%) 16/20 (80%)
ontransformed plant extracts 0/6 (0%) 0/6 (0%)
ock immunized 0/6 (0%) 0/6 (0%)
a Protection is expressed as number of protected mice/number of
hallenged mice.romoters and, principally, the adaptation of the codon csage in the foreign genes to that used in plants could
mprove expression levels.
In summary, the results presented here support the
oncept of using transgenic plants as a novel and safe
ystem for vaccine production, which could become a
ery attractive alternative in the developing world. The
act that feeding mice transgenic plants expressing a
ecombinant antigen caused an oral immune response
emonstrates the feasibility of using transgenic plants as
xpression and delivery systems for oral vaccines, even
gainst those antigens for which a systemic immune
esponse is required. The establishment of food plant-
ased oral immunization method for microbial antigens
ould be an inexpensive alternative to conventional fer-
entation systems for vaccine production, as food plants
an be grown inexpensively in large quantities and are
asily administered.
MATERIALS AND METHODS
roduction of transgenic plants of alfalfa
A 655-bp DNA fragment encoding the VP1 gene was
mplified by RT-PCR from viral RNA using specific prim-
rs (forward primer, 59 AGCGGATCCTGTCATGGCCACT-
TTGAA 39; reverse primer, 59 AAGGGGATCCTCTA-
AGTCTACTTCAG 39) and cloned into the binary pRok2
lasmid (Baulcombe et al., 1986) under the control of the
auliflower mosaic virus (CaMV 35S) promoter (recom-
inant plasmid pRok.VP1a). The designed recombinant
roduct starts at codon 13 of the native VP1 gene and
ontains the complete gene sequence including its na-
ive carboxy end. The recombinant binary vector was
ntroduced in A. tumefaciens strain LBA 4404 by electro-
oration using the procedure described by Wen-Jun and
orde (1989). Petioles of alfalfa clone C2-3, kindly pro-
ided by Drs. B. McKersie and S. Bowley (Plant Biotech-
ology Division, Department of Plant Agriculture, Univer-
ity of Guelph, Guelph, Ontario, Canada) were coculti-
ated with A. tumefaciens and cultured in vitro as
escribed by Shetty and McKersie (1993). The in vitro
election was performed using 50 mg/ml of kanamycin
s described by McKersie et al. (1993).
TABLE 2
Protection against FMDV Challenge in Mice Fed Plant Leaves
Mice fed with
Protection ratea
Experiment A Experiment B
Rok.VP1a plant leaves 6/9 (66%) 6/8 (75%)
ontransformed plant leaves 0/5 (0%) 0/6 (0%)
ock immunized 0/5 (0%) 0/6 (0%)
a Protection is expressed as number of protected mice/number of
hallenged mice.
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352 WIGDOROVITZ ET AL.CR and RT-PCR analyses
The presence of the recombinant genes in transgenic
lfalfa plants was detected by PCR (Carrillo et al., 1998).
otal nucleic acids were extracted from samples of ap-
roximately 50 mg of leaves following the protocol de-
cribed by Klimyuk et al. (1993). The VP1 gene was
mplified using a pair of primers that span from position
3 of VP1 (forward primer, 59 AGCGGATCCTGTCATGGC-
ACTGTTGAA 39) to position 27 of p52 (reverse primer,
9 AAGGGGATCCTCTAGAGTCTACTTGAG 39). The pres-
nce of the nptII gene, which confers resistance to kana-
ycin, was detected by PCR using a pair of specific
rimers (forward primer, 59 CAGACAATCGGCTGCTCT-
AT 39; reverse primer, 59 TGCGATGTTTCGCTTGGTGT
9) that amplify an internal fragment of 344 bp (Desgane´s
t al., 1995). PCRs were performed in a 50-ml final reac-
ion volume, containing 5 ml of plant DNA, 2.5 mM MgCl2,
00 mM of dNTPs, and 0.5 mM of each primer.
The transcription of the transgenes was analyzed by
pecific amplification of VP1 transcripts from plant ex-
racts. Total RNA extraction was performed from 1 g of
resh alfalfa leaves, which were ground in the presence
f liquid nitrogen and resuspended in 2 ml of TE and 8 ml
f Trizol (Gibco BRL). After chloroform extraction (0.2 ml
f chloroform per milliliter of plant suspension) the aque-
us phase was precipitated with 0.5 ml of isopropanol
er milliliter of plant extract. Pellets were washed with
0% ethanol, dried, and resuspended in 200 ml of TE.
NA was digested with RNase-free DNase (Boehringer).
he absence of residual DNA in the RNAs obtained was
hecked by PCR. RT reaction was carried out in a 50-ml
inal reaction volume that contained 2 mM random prim-
ng hexamers and a mixture of dNTPs (at a concentration
f 1 mM/each), 1 unit of RNase inhibitor, and 10 units of
MLV-RT enzyme in 13 RT buffer. The mixture was
ncubated for 30 min at 37°C and then inactivated for 10
in at 95°C. Samples were cooled and held at 220°C
ntil used for PCR amplification. PCR was performed
sing primers that specifically amplify a 145-bp fragment
f the VP1 gene between positions 369 and 490 (forward
rimer, 59 CCGGATCCTGGCAACATGTACA 39; reverse
rimer, 59 GGTCGCATATGTGGCACCGTAGTT 39). As pos-
tive control for RNA extraction, a fragment of approxi-
ately 800 bp that encompasses the 5.8S mRNA gene
nd the flanking intragenic transcribed spacers (ITS) was
mplified using specific primers (forward primer, 59
GAAGGAGAAGTCGTAACAAGG 39; reverse primers, 59
CCTCCGCTTATTGATATGC 39). The same nptII primers
escribed above for the PCR technique were used as an
dditional control for RNA detection.
nalysis of foreign protein expression in transgenic
lants
The screening of the recombinant plants was per-
ormed by ELISA. Ninety-six-well Immulon 2 ELISA plates pDynatech) were coated with a rabbit anti-FMDV anti-
erum in carbonate buffer, pH 9.6, for 12 h at 4°C. Plates
ere then washed three times with PBS containing
.05% Tween 20 (PBST) and blocked with 3% horse se-
um in PBST for 2 h at 37°C (all subsequent steps were
erformed using this buffer). A four fold dilution of leaf
xtracts from the plants to be tested was then added and
ncubated for 1 h at 37°C. Plates were washed and a
ool of mouse anti-FMDV antiserum was added and
ncubated for 1 h at 37°C. Plates were washed again and
ncubated for 45 min at 37°C with peroxidase-labeled
abbit anti-mouse Ig (Dakkopats). After five washes, the
eaction was developed by addition of o-phenylenedi-
mine–H2O2 in citrate buffer, pH 5, and read 3 min later
t 490 nm in an MR 500 Microplate Reader (Dynatech).
lants presenting consistently (in at least three consec-
tive independent determinations) OD readings of 3
tandard deviations (SD) over the nontransgenic plant
sed as control were selected for further studies.
nalysis of antibody response to plant-expressed VP1
olypeptides
Adult (60 to 90 days old) male BALB/c mice were
mmunized intraperitoneally on days 0, 15, 30, and 45
ith either leaf extracts from transgenic plants express-
ng VP1 or leaf extracts from nontransformed plants of
lfalfa (150 ml of leaf extract, containing 15 to 20 mg of
resh leaf tissue, in incomplete Freund’s adjuvant per
nimal per injection). Orally immunized mice were fed
hree times a week, for 2 months with approximately
.3 g of freshly harvested leaves each time.
Mouse sera were evaluated for the presence of anti-
MDV-specific antibodies by ELISA and Western blot.
ELISA. ELISA was performed using as antigen either a
ynthetic peptide (p135-160), which represents the amino
cid residues of FMDV VP1 O1C between positions 135
nd 160 (Zamorano et al., 1995), or complete FMDV
articles. The assay was performed as described for
etection of VP1 in transgenic plants for the capture of
ntigen to the plate, blocking, washing, developing, and
eading steps (Pe´rez Filgueira et al., 1995). In the case of
135-160, peptide was directly adsorbed to the plate at a
oncentration of 15 mg/ml. To detect anti-virus particle
ctivity, purified FMDV particles (produced, inactivated,
nd purified as described in Berinstein et al., 1991) were
dded to the plate (at a concentration of 1 mg/ml) after
he capturing antibody was absorbed. In either case,
ntigen incubation was performed for 1 h at 37°C.
ouse sera were tested in a four-fold dilution series in
locking buffer. Serum titers are expressed as the log of
he reciprocal of the highest serum dilution that gives OD
eadings above the mean OD 1 3 SD of sera from five
nimals immunized with nontransformed plants.
Western blot. Inactivated purified FMDV was resus-
ended in sample buffer (50 mM Tris, pH 7.5, 1 mM
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353PROTECTIVE ANTIBODY RESPONSE TO FMDV IN MICE IMMUNIZED WITH TRANSGENIC PLANTSMSF, 8 M urea, 1% SDS, 2 mM DTT, and 2% 2-bME),
oiled for 10 min, electrophoresed in 12.5% SDS–PAGE,
nd blotted to an Immobilon P (Millipore) membrane. The
embrane was blocked overnight with PBST containing
% skim milk (all subsequent steps were performed
sing this buffer) and incubated with the corresponding
ouse sera (diluted 1/20) for 2 h at 37°C. The membrane
as then washed using PBST and incubated with an
lkaline phosphatase labeled anti-mouse Ig rabbit anti-
erum (Dakkopats) for 1 h at 37°C. After being washed
hree times the reaction was developed by the addition
f the substrate NBT/CIP.
hallenge experiments
Mice were challenged ip with 104 SM50LD. Protection
as determined by absence of viremia in the challenged
ice at 36 h postinfection. Viremia was tested by im
noculation of 50 ml of a 1/10 dilution of peripheral blood
o a 5- to 6-day-old litter of six mice per blood sample.
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